Search results :

Nuvocid

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01XA05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1
Nausea Nausea 9.94% - 10.5% x
Headache Headache 6.71% - 7.07% x
Vomiting Vomiting 4.61% - 4.68% x
Diarrhoea Diarrhoea 3.26% - 3.69% x
Abscess Abscess 2.34% - 3.79% x
Infusion site reaction Infusion site reaction 1.95% - 3.46% x
Dizziness Dizziness 2.64% - 2.66% x
Alanine aminotransferase increased Alanine aminotransferase increased 1.53% - 2.77% x
Infusion site phlebitis Infusion site phlebitis 1.53% - 2.46% x
Tachycardia Tachycardia 1.12% - 2.46% x
Aspartate aminotransferase increased Aspartate aminotransferase increased 1.53% - 1.84% x
Anaemia Anaemia x
Angioedema Angioedema x
Bronchospasm Bronchospasm x
Cellulitis Cellulitis x
Infection Infection x
Connective tissue disorder Connective tissue disorder x
Eosinophilia Eosinophilia x
Erythema multiforme Erythema multiforme x
Dermatitis Rash x
Rash Rash x
Extravasation Extravasation x
Gastrointestinal disorder Gastrointestinal disorder x
Cardiac disorder Cardiac disorder x
Hypersensitivity Hypersensitivity x
Hypoglycaemia Hypoglycaemia x
Immune system disorder Immune system disorder x
Mediastinal disorder Mediastinal disorder x
Nervous system disorder Nervous system disorder x
Osteomyelitis Osteomyelitis x
Pruritus Pruritus x
Tenosynovitis Tenosynovitis x
Urticaria Urticaria x
Wheezing Wheezing x
Oedema peripheral Oedema peripheral x
Leukocytoclastic vasculitis Allergic cutaneous angiitis x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Myalgia Myalgia x
Musculoskeletal discomfort Myalgia x
Induration Induration x
Blood uric acid increased Hyperuricaemia x
Hyperuricaemia Hyperuricaemia x
Blood bilirubin increased Bilirubin total increased x
Infestation Infestation NOS x
Infusion site erythema Infusion site erythema x

Indications

No indications were found.

ORITAVANCIN

Side effects:44
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label